Singular Genomics Systems Stock Volatility
| OMIC Stock | USD 21.90 0.09 0.41% |
Singular Genomics is very risky given 3 months investment horizon. Singular Genomics Systems owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.17, which indicates the firm had a 0.17% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.97% are justified by taking the suggested risk. Use Singular Genomics Systems Risk Adjusted Performance of 0.1313, coefficient of variation of 627.69, and Semi Deviation of 2.78 to evaluate company specific risk that cannot be diversified away. Key indicators related to Singular Genomics' volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Singular Genomics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Singular daily returns, and it is calculated using variance and standard deviation. We also use Singular's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Singular Genomics volatility.
Singular |
ESG Sustainability
While most ESG disclosures are voluntary, Singular Genomics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Singular Genomics' managers and investors.Environmental | Governance | Social |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Singular Genomics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Singular Genomics at lower prices to lower their average cost per share. Similarly, when the prices of Singular Genomics' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving together with Singular Stock
Moving against Singular Stock
Singular Genomics Market Sensitivity And Downside Risk
Singular Genomics' beta coefficient measures the volatility of Singular stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Singular stock's returns against your selected market. In other words, Singular Genomics's beta of 0.64 provides an investor with an approximation of how much risk Singular Genomics stock can potentially add to one of your existing portfolios. Singular Genomics Systems is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Singular Genomics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Singular Genomics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Singular Genomics Systems Demand TrendCheck current 90 days Singular Genomics correlation with market (Dow Jones Industrial)Singular Beta |
Singular standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 17.65 |
It is essential to understand the difference between upside risk (as represented by Singular Genomics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Singular Genomics' daily returns or price. Since the actual investment returns on holding a position in singular stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Singular Genomics.
Singular Genomics Systems Stock Volatility Analysis
Volatility refers to the frequency at which Singular Genomics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Singular Genomics' price changes. Investors will then calculate the volatility of Singular Genomics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Singular Genomics' volatility:
Historical Volatility
This type of stock volatility measures Singular Genomics' fluctuations based on previous trends. It's commonly used to predict Singular Genomics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Singular Genomics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Singular Genomics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Singular Genomics Systems Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Singular Genomics Projected Return Density Against Market
Given the investment horizon of 90 days Singular Genomics has a beta of 0.6404 . This indicates as returns on the market go up, Singular Genomics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Singular Genomics Systems will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Singular Genomics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Singular Genomics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Singular stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Singular Genomics Systems has an alpha of 2.6713, implying that it can generate a 2.67 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Singular Genomics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Singular Genomics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Singular Genomics is 594.27. The daily returns are distributed with a variance of 311.59 and standard deviation of 17.65. The mean deviation of Singular Genomics Systems is currently at 6.91. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | 2.67 | |
β | Beta against Dow Jones | 0.64 | |
σ | Overall volatility | 17.65 | |
Ir | Information ratio | 0.15 |
Singular Genomics Stock Return Volatility
Singular Genomics historical daily return volatility represents how much of Singular Genomics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 17.652% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7502% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Singular Genomics Volatility
Volatility is a rate at which the price of Singular Genomics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Singular Genomics may increase or decrease. In other words, similar to Singular's beta indicator, it measures the risk of Singular Genomics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Singular Genomics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Market Cap | 33.5 M | 31.8 M |
Singular Genomics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Singular Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Singular Genomics' price varies over time.
3 ways to utilize Singular Genomics' volatility to invest better
Higher Singular Genomics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Singular Genomics Systems stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Singular Genomics Systems stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Singular Genomics Systems investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Singular Genomics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Singular Genomics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Singular Genomics Investment Opportunity
Singular Genomics Systems has a volatility of 17.65 and is 23.53 times more volatile than Dow Jones Industrial. 96 percent of all equities and portfolios are less risky than Singular Genomics. You can use Singular Genomics Systems to enhance the returns of your portfolios. The stock experiences a normal upward fluctuation. Check odds of Singular Genomics to be traded at $23.0 in 90 days.Significant diversification
The correlation between Singular Genomics Systems and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Singular Genomics Systems and DJI in the same portfolio, assuming nothing else is changed.
Singular Genomics Additional Risk Indicators
The analysis of Singular Genomics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Singular Genomics' investment and either accepting that risk or mitigating it. Along with some common measures of Singular Genomics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.1313 | |||
| Market Risk Adjusted Performance | 4.31 | |||
| Mean Deviation | 6.78 | |||
| Semi Deviation | 2.78 | |||
| Downside Deviation | 4.07 | |||
| Coefficient Of Variation | 627.69 | |||
| Standard Deviation | 17.34 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Singular Genomics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Singular Genomics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Singular Genomics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Singular Genomics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Singular Genomics Systems.
Complementary Tools for Singular Stock analysis
When running Singular Genomics' price analysis, check to measure Singular Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Genomics is operating at the current time. Most of Singular Genomics' value examination focuses on studying past and present price action to predict the probability of Singular Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Genomics' price. Additionally, you may evaluate how the addition of Singular Genomics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |